Clinical Trial Update: SEA-SIDE: Sirolimus Versus Everolimus-eluting Stent Randomized Assessment in Bifurcated Lesions and Clinical SIgnificance of Residual siDE-branch Stenosis [Phase 4]

View source ↗

Summary

Phase 4 randomized study comparing sirolimus-eluting versus everolimus-eluting stents in bifurcated coronary lesions, assessing the clinical impact of residual …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Artery Stenosis

Drugs mentioned

• Everolimus (everolimus)
• Sirolimus (Sirolimus)

Snippet

Sponsor: Catholic University of the Sacred Heart | Conditions: Coronary Artery Disease, Coronary Stenosis | Phase 4 | Status: COMPLETED